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Pancreaticneoplasmsinchildrenarerare.Hereinisreportedthecaseofafour-year-oldgirlwhosemotherwasexposedtoradiation
atChernobylthatpresentedwithobstructivejaundiceandamasssuspectedonCTanddiagnosedbyendoscopicultrasound(EUS)
withﬁneneedleaspiration(FNA).ThischildisprobablytheyoungestcaseofapplicationoflinearEUSwithbiopsytobedescribed.
The diagnosis, management, and followup of children with this rare tumor are discussed.
1.Introduction
Pancreatic tumors in childhood are rare. Most specialists see
few during their career. These tumors range in spectrum
from benign duplication cysts, to primary pancreatic tumors
to rare metastatic lesions, and primary lesions include
the rare lymphoma or neuroendocrine tumors [1]. The
presurgical workup for such patients is critical for ensuring
optimal outcomes. Herein is reported a case of a four-
year-old girl who presented with obstructive jaundice. EUS-
guided FNA diagnosed a neuroendocrine tumor in the head
of the pancreas with lymph node metastases.
2. Case Presentation
A four-year-old previously healthy girl presented with two
months of abdominal pain and ten days of jaundice and
acholic stools. There was no recent weight loss, no nausea
or vomiting, fever, or change in mental status. There was no
history of recent travel or trauma. There is no family history
of pancreatic tumors in the past. The patients’ mother had
been exposed to radiation from Chernobyl in the former
Soviet Union in 1989 and suﬀers from an unknown thyroid
ailment.Themothertakesnomedicationforherthyroidand
has not had any surgery for a thyroid disorder.
On physical examination the child was jaundiced and
had a palpable mass in the right upper quadrant that was
nontender. The rest of her physical exam was unremarkable.
Her laboratory results were remarkable for elevated direct
bilirubin, LDH, GGTP, and alkaline phosphatase. Her alpha-
fetoprotein, CEA and CA-125, were normal, her CA19-9 was
elevated (see Table 1). All of her blood counts were within
normal limits as were her coagulation tests. Fasting blood
glucose analysis was normal on multiple tests.
A CT scan revealed a 3cm suspicious area in the head
of the pancreas with dilatation of both the pancreatic and
common bile ducts (Figures 1(a) and 1(b)). The gallbladder
was markedly distended as were the intra-hepatic biliary2 Case Reports in Gastrointestinal Medicine
Table 1:Initialbloodtestvalues(units/literandgram/liter),1KU/L
means 103 units/liter, bold values are out of range.
Test Value Normal range
Serum amylase 20U/L 30–140U/L
Alkaline phosphatase 1167U/L 50–160U/L
Lactate Dehydrogenase 334U/L 60–225U/L
Gamma-glutamyl transferase 1473U/L 50–60U/L
Alpha-fetoprotein <2KU/L 0–8KU/L
CA-125 10.6KU/L 0–35KU/L
CA-19-9 163KU/L 0–28KU/L
Bilirubin-direct 4.6 ·10−2 g/L <0.4·10−2 g/L
CEA 0.6·10−6 g/L 0–3·10−6 g/L
radicles. A CT of the chest was negative/normal. Endoscopic
ultrasound (Pentax FG38) revealed a well-circumscribed
3cm lesion. FNA biopsy was performed (Figure 1(c)), and
the results were consistent with a low-grade malignant
epithelial tumor, most likely a nonfunctioning pancreatic
neuroendocrine tumor, based on positive synaptophysin and
chromogranin stains.
At laparotomy a large tumor in the head of the pancreas
was palpated. In addition, several peripancreatic lymph
nodes appeared grossly enlarged. A nonpylorus sparing
Whipple procedure was performed including removal of
the peripancreatic lymph nodes. The ﬁnal pathology of
the sample was a well-diﬀerentiated, non-functioning neu-
roendocrine carcinoma with 3 out of 12 lymph nodes
sampled positive for tumor. There was no extension into the
surrounding tissues or duodenum.
The patient had an uneventful postoperative recovery,
tolerated a regular diet on postoperative day 5, and was
discharged on the 9th postoperative day.
Pediatric oncologic consultation chose the “wait and
see” approach, with no postoperative adjuvant therapy being
administered.18monthslater,thechildisapparentlyhealthy,
growing well, and with no current signs of disease.
3. Discussion
Primary pancreatic tumors in childhood are rare. Two of
the largest series reported 17 and 25 patients each over
the course of 30 years. In all series reported to date, the
majorityofthesetumorsaresolidpseudopapillary tumorsor
pancreatoblastomas. Pancreatic NETs comprise a small, less
than 20%, subset of these cases [2, 3].
Pancreatic neuroendocrine tumors are a subset of
gastroenteropancreatic neuroendocrine tumors and can
be broadly divided into functioning and non-functioning
tumors based on their physiologic activity. In addition,
the WHO divides these tumors into three broad cate-
gories based on tumor diﬀerentiation: well diﬀerentiated
neuroendocrine tumor, well-diﬀerentiated neuroendocrine
carcinoma, and poorly-diﬀerentiated endocrine carcinoma.
Functioning tumors can arise from any of the neuroen-
docrine system. These tumors are usually sporadic but can
be associated with genetic syndromes such as MEN-1, von
Hippel-Lindau, neuroﬁbromatosis 1, and tuberous sclerosis.
Whatever the etiology, pancreatic neuroendocrine tumors
are rare and are reported to be less than 3% of all primary
pancreatic neoplasms [4].
The case presented here is unique for several reasons.
The ﬁrst is the age of the child. Of all the pancreatic
neuroendocrine tumors reported in children, only one other
hasbeenasyoungasthechilddescribedhere[2].Inaddition,
the mother of our patient reported an exposure to radiation
from the Chernobyl reactor. Though it is impossible to
know for sure if there is a correlation between the mothers
“exposure and her child’s [sic]” tumor, it is an interesting
association, especially in such a young child.
Radiation exposure, such as the accident at Chernobyl,
has led to increases in certain cancers, most notably thyroid
cancerinchildrenwhowereexposedandoﬀspringofparents
who were exposed. Elevated levels of Cs-137 have been
documented in the endocrine glands of children exposed at
Chernobyl particularly the pancreas, thyroid, and adrenals.
In autopsy specimens examined children had signiﬁcantly
higher levels than adults who lived in the same geographic
area of Belarus during the same time period of exposure
[5]. Moreover, genetic mutations have been described in
the oﬀspring of people exposed to radiation at Chernobyl
that were not present in oﬀspring born before the exposure
and that are not present in control children of parents
not exposed at Chernobyl [6]. There has, however, been
no demonstrated association between radiation exposure at
Chernobyl and pancreatic neoplasms.
Endoscopic ultrasound-(EUS) guided biopsy is a well-
described technique in the workup of pancreatic lesions in
adults and has also been described in children. Previous
reports have described the use of EUS in children to
distinguish a true pancreatic neoplasm from jaundice due
to pancreatitis in the head of the pancreas [7]. Most
of these cases are in older children and adolescents. No
published report was found of using the linear FG 38
13mm echoendoscope used for taking FNA samples in such
a young child. General anesthesia was performed by an
anesthesiologist, without endotracheal intubation, so as not
to make intubation of the large scope any harder. EUS
demonstrated a well circumscribed mass in the head of
the pancreas (Figure 1(c)) which was suggestive of a true
neoplasm and not an inﬂammatory process. The nearly
isoechoic pattern was most typical for a neuroendocrine
tumor, the imaging unable to diﬀerentiate a neuroendocrine
tumor from a neuroendocrine carcinoma. The common bile
duct was dilated, no signs of vascular invasion or of liver or
other distal metastasis were identiﬁed. The wide CBD seen in
the ﬁgure takes into account the small size of the patient. The
FNA-transduodenal biopsy (EUSN3 needle, Wilson-Cook
Corporation) was important in diﬀerentiating this primary
pancreatic lesion from any metastatic lesion. Cytology
specimens stained strongly positive for both synaptophysin
and chromogranin, deﬁnitively making the diagnosis of
neuroendocrine tumor. The only elevated “tumor marker”
was CA 19-9, which is often a nonspeciﬁc marker of biliary
obstruction that can be elevated to the levels seen in theCase Reports in Gastrointestinal Medicine 3
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Figure 1: (a) CT Scan of Abdomen: Mass (Arrow) in head of pancreas. (b) CT Scan of Abdomen: Dilated Common (large arrow) and
Pancreatic (Double arrow) ducts. (c) Endoscopic ultrasound image of lesion in head of pancreas.
presentcaseinmalignantaswellasnon-malignantprocesses,
of the pancreas and of other organs [8].
The treatment and followup of non-functioning pancre-
atic neuroendocrine tumors is poorly deﬁned. Most treat-
ment and outcome studies of non-functioning pancreatic
neuroendocrine tumors are in adults. In these studies, the
long-term survival for a well-diﬀerentiated non-functioning
carcinoma, such as in this child here, is approximately 50%
at ﬁve-year followup. Despite these statistics, there is little
to oﬀer these patients in terms of adjuvant chemotherapy,
or radiation and surgery with curative intent remains the
treatment of choice. Resection of liver metastasis is the
recommended treatment for patients with multiple liver
metastases. Somatostatin analogs as well as streptozotocin
and 5-FU have been recommended in cases where tumor
has recurred and is deemed nonresectable. These patients
can be followed with periodic ultrasounds as most tumor
recurrence is in the liver.
Other studies such as PET scans and isotope-linked
octreotide scans have been described but only on an
experimental basis [4].
Pancreatic neuroendocrine tumors remain a rare pri-
mary pancreatic neoplasm described mostly in adults.
Diagnostic possibilities considered included lymphoma,
nonsecreting neuroendocrine tumor, solid and cystic pseu-
dopapillary tumor, acinar cell tumor, autoimmune pancre-
atitis, and pancreatoblastoma. Pancreatic neuroendocrine
tumors are rare in children but appear in about 5%
of primary pancreatic neoplasms described in adults [9].
Treatment options for this tumor are limited, and it is
best treated with surgical resection. Followup is clinical,
other than the possible addition of serum chromogranin
a ,am a r k e ro fn e u r o e n d o c r i n et u m o r s ,w h i c hh a sb e e n
negative in this patient [10]. Herein is described a four-year-
old girl, one of the youngest presented to date, who is the
daughter of a woman exposed to radiation at Chernobyl.
The diagnosis was established by EUS and biopsy. This child
is probably the youngest case of application of linear EUS
with biopsy to be described. A major goal of this report was
to inform others that the large scope can be used in such
small children successfully to establish clinically important
diagnoses. While this report advocates for an innovative use
of the EUS and FNA for a very small child, this case perhaps
would not be considered appropriate for performance by a
fellow, despite the very good results found by trainees in the
recent report by Cot´ e et al. [11] on the training and success
rates of EUS-guided FNA amongst experienced versus in-
training echoendoscopists.4 Case Reports in Gastrointestinal Medicine
In followup a small child presented with a tumor
metastatic to a few of the regional lymph nodes which were
excised. Now, 18 months later, with no further medical care
other than clinical followup, the patient is thriving and well.
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